HEART MORPHOLOGICAL CHANGES IN METABOLIC SYNDROME AND THEIR ROLE IN CARDIOVASCULAR RISK AND TREATMENT STRATEGIES
;
Metabolic syndrome, cardiovascular risk, left ventricular hypertrophy, myocardial fibrosis, cardiac morphology, insulin resistance, chronic inflammation, oxidative stress, heart failure, treatment strategies, early detection, arrhythmiasAbstrak
Metabolic syndrome (MetS) is a group of interconnected risk factors that significantly increase the likelihood of cardiovascular diseases, type 2 diabetes, and other metabolic disorders. Among the various components of MetS, morphological changes in the heart are becoming increasingly recognized for their role in cardiovascular dysfunction. This article explores the key morphological alterations in the heart associated with MetS, including left ventricular hypertrophy, myocardial fibrosis, and changes in heart chamber dimensions. The underlying mechanisms, such as insulin resistance, chronic inflammation, and oxidative stress, contribute to these structural changes, leading to impaired cardiac function and an elevated risk of heart failure, arrhythmias, and coronary artery disease. The article further discusses the implications of these changes for cardiovascular health, emphasizing the importance of early detection and intervention. Finally, it outlines potential treatment strategies aimed at preventing or reversing these cardiac alterations to improve long-term cardiovascular outcomes in individuals with MetS.
Iqtiboslar
Иргашев, И. Э. (2024). ПРИНЦИПЫ ПРИОРИТЕТА И ЕГО ЗНАЧЕНИЕ ОКАЗАНИЯ ПЕРВОЙ ПОМОЩИ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ. TADQIQOTLAR. UZ, 34(2), 177-184.
Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.
Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.
Эргашева, Г. Т. (2024). СНИЖЕНИЕ РИСКА ОСЛОЖНЕНИЙ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 210-218.
Нарзуллаева, У., Самиева, Г., & Пардаева, З. (2020). ПАТОФИЗИОЛОГИЯ РЕПЕРФУЗИОННОГО ПОВРЕЖДЕНИЯ МИОКАРДА. Журнал вестник врача, 1(2), 155-158.
Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.
Zikrillaev, F. A. (2024). Cardiorehabilitations from Physiotherapeutic Treatments in Cardiovascular Diseases. American Journal of Bioscience and Clinical Integrity, 1(10), 96-102.
Зикриллаев, Ф. А. (2024). ОПРЕДЕЛЕНИЕ РАННИХ ФАКТОРОВ РИСКА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК В ПУБЕРТНОМ ВОЗРАСТЕ. Modern education and development, 16(7), 166-180.
Зикриллаев, Ф. А. (2024). РОЛЬ ПРЕПАРАТОВ ЛЕРКАНИДИПИНА И АМЛОДИПИНА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК. Modern education and development, 16(7), 213-229.
Abdurashitovich, Z. F. (2024). DETERMINATION OF THE ETIOPATHOGENESIS AND RISK FACTORS OF OBESITY AMONG ADOLESCENTS. Modern education and development, 16(7), 181-194.
Abdurashitovich, Z. F. (2024). EARLY RISK FACTORS FOR ARTERIAL HYPERTENSION AND FEATURES OF ITS ASSOCIATION WITH OTHER DISEASES. Modern education and development, 16(7), 195-212.
Ergasheva, G. (2023). METHODS TO PREVENT SIDE EFFECTS OF DIABETES MELLITUS IN SICK PATIENTS WITH TYPE 2 DIABETES. International Bulletin of Medical Sciences and Clinical Research, 3(10), 104-108.
Ergasheva, G. T. (2022). QANDLI DIABET BILAN KASALLANGANLARDA REABILITATSIYA MEZONLARINI TAKOMILASHTIRISH. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 335-337.
ГТ, Э., & Саидова, Л. Б. (2022). СОВЕРШЕНСТВОВАНИЕ РЕАБИЛИТАЦИОННО-ВОССТАНОВИТЕЛЬНЫХ КРИТЕРИЕВ БОЛЬНЫХ С СД-2 ТИПА. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 206-209.
Toxirovna, E. G. (2023). O’RTA VA KEKSA YOSHLI BEMORLARDA 2-TUR QANDLI DIABET KECHISHINING KLINIKO-MORFOLOGIK XUSUSIYATLARI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 33(1), 164-166.
Abdurashitovich Z. F. ODAM ANATOMIYASI FANIDAN KALLA SUYAKLARI TUZILISHI VA SHAKLLANISHI HAQIDA //Modern education and development. – 2024. – Т. 16. – №. 7. – С. 149-165.
Zikrillaev, F. A. (2024). Metabolic Syndrome Calling Models. American Journal of Bioscience and Clinical Integrity, 1(11), 66-71.
Abdurashitovich, Z. F. (2024). MUSHAKLAR TO’GRISIDA MA’LUMOT. MUSHAKLARNING TARAQQIYOTI. MUSHAKLARNING YORDAMCHI APPARATI. TADQIQOTLAR. UZ, 40(3), 94-100.
Abdurashitovich, Z. F. (2024). APPLICATION OF MYOCARDIAL CYTOPROTECTORS IN ISCHEMIC HEART DISEASES. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 39(5), 152-159.
Abdurashitovich, Z. F. (2024). SIGNIFICANCE OF BIOMARKERS IN METABOLIC SYNDROME. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(9), 409-413.
